Cargos activos de Heiko von der Leyen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ORGENESIS INC. | Director Técnico/Científico/I+D | 01/09/2020 | - |
Historial de carrera de Heiko von der Leyen
Antiguos cargos conocidos de Heiko von der Leyen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01/01/2005 | 01/01/2017 |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Director Técnico/Científico/I+D | 01/01/2003 | 01/01/2004 |
Artiss GmbH | Director Técnico/Científico/I+D | 01/01/2001 | 01/01/2002 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Director Técnico/Científico/I+D | 01/01/1998 | 01/01/2001 |
Estadísticas
Internacional
Alemania | 5 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ORGENESIS INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Hannover Clinical Trial Center GmbH | |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | Health Technology |
Artiss GmbH | |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Heiko von der Leyen
- Experiencia